Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
暂无分享,去创建一个
Agnès Laplanche | Michel Ducreux | M. Ychou | M. Ducreux | D. Elias | P. Lasser | V. Boige | A. Laplanche | E. Gamelin | F. Viret | Valérie Boige | Dominique Elias | F. Quénet | Erick Gamelin | Marc Ychou | François Quenet | Philippe Lasser | Fares Husseini | Frédéric Viret | Jacques-Henri Jacob | Jean-Robert Delperro | Monique Luboinski | M. Luboinski | J. Jacob | F. Husseini | J. Delperro
[1] C. Tournigand,et al. FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] E. Raymond,et al. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers , 1997, Anti-cancer drugs.
[3] M. Ducreux,et al. Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model , 2004, Anti-cancer drugs.
[4] K. Rothman. Estimation of confidence limits for the cumulative probability of survival in life table analysis. , 1978, Journal of chronic diseases.
[5] P. Rougier,et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] B. Nordlinger,et al. Nonsurgical methods for liver metastases including cryotherapy, radiofrequency ablation, and infusional treatment: what's new in 2001? , 2002, Current opinion in oncology.
[7] J. Pignon,et al. Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy. , 1991, European journal of cancer.
[8] Chen Hs,et al. Intra-arterial infusion of anticancer drugs: theoretic aspects of drug delivery and review of responses. , 1980 .
[9] V. Sondak,et al. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. , 1996, Journal of the National Cancer Institute.
[10] L. Zelek,et al. Multimodal therapy with intravenous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Research in Oncology trial). , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] R. Simon,et al. Optimal two-stage designs for phase II clinical trials. , 1989, Controlled clinical trials.
[12] P. Piedbois. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] M. Gonen,et al. Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] W. Hiddemann,et al. Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] L. Schwartz,et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] D. Kerr,et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial , 2003, The Lancet.
[17] J. Ferlay,et al. Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .
[18] M. Ychou,et al. Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] L. Wiseman,et al. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. , 2000, Drugs.
[20] M. Buyse,et al. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] C. Breedis,et al. The blood supply of neoplasms in the liver. , 1954, The American journal of pathology.
[22] K. Abrams,et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases , 1994, The Lancet.
[23] R. Fitzgibbons,et al. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] C. Porta,et al. Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study , 2001, Cancer Chemotherapy and Pharmacology.
[25] R. Fischbach,et al. Treatment of liver metastases from colorectal cancer. , 1996, Anticancer research.
[26] P. Rougier,et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] W. Gaus,et al. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial , 1989, Cancer.
[28] L. Saltz,et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. , 2000, The New England journal of medicine.
[29] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .
[30] D. Morton,et al. Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases , 2002, Annals of Surgical Oncology.
[31] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[32] R. James,et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.